Literature DB >> 14569758

Risk factors for infection in total knee replacement surgery at hospital Kuala Lumpur.

A B Syahrizal1, B A Kareem, S Anbanadan, S Harwant.   

Abstract

One hundred primary TKR surgeries done between January 1994 and December 1999 were reviewed after a mean follow-up of 37.4 months. The rate of superficial and deep wound infection were 2% and 9% respectively. The most common organism in wound infection was Staphylococcus aureus. The factors that were significantly associated with superficial wound infection were diabetes mellitus (p = 0.005) and Rheumatoid arthritis (p = 0.0000). The factors that were significantly associated with deep wound infection were diabetes mellitus (p = 0.000). There was no significant difference between duration of surgery, and the mean age among patients with and without wound infections.

Entities:  

Mesh:

Year:  2001        PMID: 14569758

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  4 in total

1.  Previous fracture surgery is a major risk factor of infection after total knee arthroplasty.

Authors:  Gen Suzuki; Shu Saito; Takao Ishii; Sayaka Motojima; Yasuaki Tokuhashi; Junnosuke Ryu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-05-04       Impact factor: 4.342

2.  Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics.

Authors:  Koichi Yano; Yukihide Minoda; Akira Sakawa; Yoshihiro Kuwano; Kyoko Kondo; Wakaba Fukushima; Koichi Tada
Journal:  Acta Orthop       Date:  2009-08       Impact factor: 3.717

3.  Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis.

Authors:  Tim Bongartz; Christine S Halligan; Douglas R Osmon; Megan S Reinalda; William R Bamlet; Cynthia S Crowson; Arlen D Hanssen; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2008-12-15

Review 4.  Myths and legends in orthopaedic practice: are we all guilty?

Authors:  Nirmal C Tejwani; Igor Immerman
Journal:  Clin Orthop Relat Res       Date:  2008-08-26       Impact factor: 4.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.